Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LQDA | LIQUIDIA CORP | $6.33B | $71.23 | $56.67 | -20.45% | Buy | 6 | 70.11% | 203.29% | 560.72% | 151.62% | |||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $1.17B | $6.79 | $10.00 | 47.28% | Buy | 1 | 21.11% | 108.66% | 1,840.67% | 61.09% | |||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $37.76B | $282.85 | $433.50 | 53.26% | Strong Buy | 14 | 28.19% | 48.15% | 233.69% | 48.99% | |||
| CORT | CORCEPT THERAPEUTICS INC | $8.90B | $82.91 | $97.50 | 17.60% | Strong Buy | 4 | 31.45% | 118.55% | 189.22% | 148.15% | |||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $3.99B | $51.89 | $62.20 | 19.87% | Strong Buy | 5 | 19.71% | 36.92% | 40.49% | 29.72% | |||
| KRYS | KRYSTAL BIOTECH INC | $9.37B | $317.97 | $324.11 | 1.93% | Strong Buy | 9 | 28.50% | 20.95% | 67.57% | 61.75% | |||
| HALO | HALOZYME THERAPEUTICS INC | $8.24B | $69.50 | $88.60 | 27.48% | Strong Buy | 5 | 13.99% | 56.04% | 525.51% | 43.18% | |||
| ADMA | ADMA BIOLOGICS INC | $1.90B | $8.21 | $19.00 | 131.43% | Strong Buy | 2 | 18.10% | 26.11% | 98.42% | 57.75% | |||
| ASND | ASCENDIS PHARMA A | $13.54B | $218.06 | $307.20 | 40.88% | Strong Buy | 10 | 34.10% | 9.77% | 263.27% | 64.13% | |||
| VCEL | VERICEL CORP | $1.91B | $37.46 | $53.00 | 41.48% | Strong Buy | 2 | 16.37% | 47.55% | 24.71% | 18.13% | |||
| ZVRA | ZEVRA THERAPEUTICS INC | $747.81M | $12.65 | $29.83 | 135.83% | Strong Buy | 6 | 37.25% | 7.50% | 100.35% | 74.13% | |||
| RPRX | ROYALTY PHARMA PLC | $31.60B | $54.87 | $61.00 | 11.17% | Strong Buy | 4 | 14.94% | 46.46% | 41.61% | 20.87% | |||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $10.81B | $55.95 | $88.65 | 58.44% | Strong Buy | 17 | 15.27% | 73.13% | 26.09% | 18.87% | |||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $14.47B | $230.56 | $259.25 | 12.44% | Strong Buy | 12 | 6.68% | 297.12% | 47.43% | 18.13% | |||
| TGTX | TG THERAPEUTICS INC | $7.58B | $49.52 | $51.67 | 4.34% | Buy | 3 | 32.29% | 0.06% | 104.97% | 40.04% | |||
| TECH | BIO-TECHNE CORP | $8.45B | $54.00 | $64.86 | 20.11% | Buy | 7 | 4.87% | 48.53% | 19.35% | 15.82% | |||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $1.99B | $34.46 | $40.40 | 17.24% | Hold | 5 | 13.19% | 26.37% | 25.36% | 18.15% | |||
| LGND | LIGAND PHARMACEUTICALS INC | $5.12B | $255.54 | $270.80 | 5.97% | Strong Buy | 5 | 16.67% | 19.87% | 28.31% | 18.43% | |||
| SPRO | SPERO THERAPEUTICS INC | $165.02M | $2.85 | N/A | N/A | N/A | N/A | -21.95% | 47.53% | N/A | N/A | |||
| NAGE | NIAGEN BIOSCIENCE INC | $274.77M | $3.45 | $10.50 | 204.35% | Strong Buy | 2 | 15.52% | 16.46% | 41.44% | 29.84% | |||
| UTHR | UNITED THERAPEUTICS CORP | $23.17B | $545.96 | $648.22 | 18.73% | Strong Buy | 9 | 11.58% | 9.04% | 32.70% | 28.74% | |||
| EXEL | EXELIXIS INC | $13.35B | $53.13 | $48.00 | -9.66% | Buy | 7 | 11.66% | 13.74% | 69.72% | 52.04% | |||
| CPRX | CATALYST PHARMACEUTICALS INC | $3.84B | $31.36 | $31.50 | 0.45% | Hold | 2 | 9.07% | 4.46% | 57.07% | 50.36% | |||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $168.39M | $2.09 | $12.00 | 474.16% | Buy | 1 | -6.05% | 5.01% | 13.31% | 8.75% | |||
| REGN | REGENERON PHARMACEUTICALS INC | $64.18B | $612.14 | $823.61 | 34.55% | Strong Buy | 18 | 9.28% | 14.80% | 24.71% | 19.00% | |||
| VRTX | VERTEX PHARMACEUTICALS INC | $112.92B | $444.93 | $558.78 | 25.59% | Strong Buy | 18 | 9.70% | 13.70% | 38.19% | 27.92% | |||
| INCY | INCYTE CORP | $21.68B | $108.53 | $107.08 | -1.34% | Buy | 13 | 7.71% | 11.61% | 13.36% | 10.24% | |||
| VCYT | VERACYTE INC | $3.78B | $47.33 | $46.33 | -2.11% | Buy | 6 | 10.69% | 4.70% | 13.14% | 12.30% | |||
| MDXG | MIMEDX GROUP INC | $536.20M | $3.60 | $8.20 | 127.78% | Strong Buy | 5 | -3.83% | 2.10% | 12.51% | 9.84% | |||
| SRPT | SAREPTA THERAPEUTICS INC | $1.62B | $15.31 | $26.33 | 72.00% | Hold | 6 | -14.08% | 2.21% | 18.77% | 8.89% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.